APA

Swinburn P., Lloyd A., Boye K. S., Edson-Heredia E., Bowman L. & Janssen B. (20140210). Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Chicago

Swinburn Paul, Lloyd Andrew, Boye K S, Edson-Heredia Emily, Bowman Lee and Janssen Bas. 20140210. Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Harvard

Swinburn P., Lloyd A., Boye K. S., Edson-Heredia E., Bowman L. and Janssen B. (20140210). Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

MLA

Swinburn Paul, Lloyd Andrew, Boye K S, Edson-Heredia Emily, Bowman Lee and Janssen Bas. Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK. : Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 20140210.